MCKESSON CORPORATION recalls
Every recall we track for MCKESSON CORPORATION — 2 in all, from 2018–2024 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
2 recalls since 2017.
All FDA recall records for MCKESSON CORPORATION since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 1 | 1 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 1 | 0 | 1 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
What to do if you have a recalled MCKESSON CORPORATION product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All MCKESSON CORPORATION recalls
2 shown- Lower riskDrug
MCKESSON CORPORATION recalls CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, Not for Oral, Ophthalmic
MCKESSON recalls CABTREO topical gel due to improper storage causing potential product degradation. This prescription-only acne treatment may be unsafe if not kept refrigerated.
MCKESSONFeb 12, 2024 - UnratedDrug
Mckesson Corporation recalls Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 cups), Rx Only, Mfg. By: Par
Mckesson recalls Megestrol Acetate Oral Suspension (400 mg/mL, 10mL) due to supert potent drug risk. Rx-only product with specific lot numbers and expiration dates. Contact for return or disposal instructions.
MckessonAug 14, 2018
MCKESSON CORPORATION recall questions
How many recalls has MCKESSON CORPORATION had?
2 recalls from MCKESSON CORPORATION are on record with U.S. safety agencies, from 2018–2024.
What is the most recent MCKESSON CORPORATION recall?
MCKESSON CORPORATION recalls CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, Not for Oral, Ophthalmic, dated Feb 12, 2024. Every MCKESSON CORPORATION recall is listed on this page, newest first.
What should I do if I have a recalled MCKESSON CORPORATION product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new MCKESSON CORPORATION recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.